The stock slipped 7% to Rs 2,425 on the BSE after the pharmaceutical company said US health regulator issued eight observations after inspecting its formulations plant at Duvvada, Visakhapatnam.
from Latest News https://ift.tt/2P0rckJ
Wednesday, 31 October 2018
Dr Reddy's slips 7% following 8 USFDA observations for Duvvada plant
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment